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Abstract
Ventral pallidum (VP) is centrally positioned within mesocorticolimbic reward circuits, and its 
dense projection to ventral tegmental area (VTA) regulates neuronal activity there. However, VP 
is a heterogeneous structure, and how this complexity affects its role within wider reward circuits 
is unclear. Here we demonstrate that projections to VTA from rostral (RVP), but not caudal VP 
(CVP) are robustly Fos-activated during cue-induced reinstatement of cocaine seeking—a rat 
model of relapse in addiction. Moreover, designer receptor-mediated transient inactivation of RVP 
neurons, their terminals in VTA, or functional connectivity between RVP and VTA dopamine 
neurons blocks the ability of drug-associated cues (but not a cocaine prime) to reinstate cocaine 
seeking. In contrast, CVP neuronal inhibition instead blocked cocaine-primed, but not cue-induced 
reinstatement. This novel double dissociation in VP sub-regional roles in drug seeking is likely 
important for understanding mesocorticolimbic circuits underlying reward seeking and addiction.
Ventral pallidum (VP) is a crucial node in ventral striatopallidal circuits underlying reward-
related behaviors, with major reciprocal connections to accumbens, extended amygdala, 
limbic thalamus, substantia nigra (SN) and ventral tegmental area (VTA)1–4. VP neurons 
respond to rewards and their cues in animals and humans, and are necessary for reward-
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seeking behaviors—leading to hypotheses that VP helps translate motivational states into 
appetitive behaviors5–7.
However, VP is a heterogeneous structure, exhibiting medial-lateral and rostral-caudal 
variation in histological markers and connectivity patterns1, 4, 8. Notably, ventromedial VP 
(most of which is located subcommissurally, rostral of bregma in rat: RVP) receives dense 
afferents from nucleus accumbens shell, and projects strongly to mediodorsal thalamus and 
VTA. Dorsolateral VP (most of which is located sublenticularlly, caudal of bregma: CVP) 
instead receives afferents from accumbens core, and projects to SN and subthalamic nucleus 
(STN), in addition to VTA1, 9. This topography implies involvement of VP subregions in 
functionally distinct mesolimbic circuits.
Functional heterogeneity between VP subregions has also been reported. In vitro, RVP and 
CVP neurons differ in several ways; many RVP neurons have spiny dendrites, glutamatergic 
afferents, hyperpolarized membrane potentials, and no spontaneous action potentials10. 
Intriguingly, these characteristics are more typical of accumbens medium spiny neurons than 
“classical” VP neurons. In contrast, CVP neurons have more “classical” pallidal 
characteristics, including aspiny dendrites, GABAergic inputs, depolarized membrane 
potentials, and spontaneous action potentials. Notably, neuronal firing during rat cocaine 
self-administration varies depending on mediolateral and rostrocaudal localization within 
VP11, and VP rostrocaudal variation exists in neuronal cytoarchitecture, in vivo firing rates, 
sensitivity to rewarding effects of electrical stimulation and microinjected drugs, opioid 
agonist-induced hedonic responses to tastes, and fMRI activation to emotionally arousing 
pictures12–19.
However, little is known about how such heterogeneity contributes to VP functions within 
wider mesolimbic circuits. In rat, CVP provides tonically-active GABA inputs to VTA and 
SN that gate firing of subpopulations of dopamine neurons and modulate reward seeking20. 
However, VP neurons are also acutely activated by reward-associated cues6, 21, 22, and VP 
projections to VTA are activated during cue-induced reinstatement of cocaine seeking23. 
How does functional-anatomical heterogeneity impact VP regulation of VTA, and the role 
of this circuit in drug seeking?
We sought to examine the roles of VP subregions and their VTA projections in relapse to 
cocaine seeking. We examined Fos activation of RVP and CVP projections to VTA, and 
inactivated these subregions or their projections to midbrain dopaminergic regions during 
reinstatement of cocaine seeking using Designer Receptors Exclusively Activated by 
Designer Drugs (DREADDs)24. DREADDs utilize endogenous G-protein signaling 
pathways, but do not affect neuronal activity in the absence of their otherwise inert, 
exogenously-administered ligand, clozapine-n-oxide (CNO). The Gi-coupled (hM4Di) 
DREADDs used here thereby allow transient inactivation of defined neuronal populations25. 
We also show that they can be used to manipulate axonal terminals of DREADD-expressing 
neurons to inactivate particular monosynaptic pathways (e.g. RVP-VTA), or to disrupt 
functional connectivity between specific neuronal populations (e.g. RVP and VTA 
dopamine neurons). We demonstrate a novel double-dissociation between rostral and caudal 
VP in cued vs. cocaine primed reinstatement respectively, and show that cued cocaine 
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seeking is dependent upon RVP projections to VTA, and complex interactions with 
dopaminergic and non-dopaminergic neurons there.
Results
Validation of VP DREADDs
We used a DREADD-based strategy to remotely control VP neurons in vivo and manipulate 
the VP-VTA circuit. We injected a synapsin-driven lentiviral vector yielding expression of 
the Gi-coupled DREADD, hM4Di24, or a control virus lacking the DREADD gene (Syn-
GFP) into RVP or CVP, and allowed animals to survive 6+ weeks before analyzing brain 
tissue for virus expression. The Syn-hM4Di-HA-GFP virus (Fig. 1a) caused robust hM4Di 
expression within RVP or CVP [visualized with immunoreactivity for the hemagglutinin 
(HA) tag, or green fluorescent protein (GFP) reporter]. These injections yielded limited 
expression outside the borders of VP (<30% labeling outside VP borders; Figs.1b–e, 2d, 
Supplemental Fig. 1). Syn-hM4Di-HA-GFP and Syn-GFP viruses yielded comparable zones 
of somatic GFP or hM4Di expression centered at the injection site [GFP: 0.82(0.21) mm3; 
hM4Di: 0.89(0.05) mm3].
We then used in vivo electrophysiology to functionally validate hM4Di receptor expression. 
In isofluorane-anesthetized rats, local CNO microinjection (60 nl,100 μM) inhibited VP 
neurons (n=24 cells; m=60.3 ± 6.6% decrease in firing; Z = −2.54; p=0.011; Fig. 1f–g). 
Local CNO similarly affected RVP (11/13 cells inhibited) and CVP (8/11 inhibited) 
neurons, with 58.2 ± 8.7% and 63.2 ± 10.6% inhibition, respectively. Pre-CNO firing rates 
in RVP (m=6.4 ± 2.0 Hz) were lower than in CVP (m=24.8 ± 5.3 Hz; p=0.007; t12=3.26), as 
previously reported10, 12.
Double Dissociation of VP Subregion Roles in Reinstatement
Next, we examined whether transient DREADD-mediated inhibition of RVP or CVP would 
attenuate either cued or cocaine primed (10 mg/kg) reinstatement of cocaine seeking 
following cocaine self-administration and extinction (Fig. 2a). CNO (0,0.1,1,10, or 20 
mg/kg) attenuated cued reinstatement in rats with hM4Di expression in RVP, but not in 
animals with comparable DREADD expression in CVP [RVP (n=16 rats): F4,39=4.0, 
p=0.008; CVP (n=17 rats): F4,46=0.59, n.s.; Fig. 2b]. In contrast, CNO (0, 10 or 20 mg/kg) 
injections attenuated cocaine-primed reinstatement only in animals with hM4Di expression 
in CVP, but not in RVP (RVP: F2,29=0.45, n.s.; CVP: F2,31=3.48, p=0.04; Fig. 2c), revealing 
a novel double-dissociation between RVP and CVP for reinstatement elicited by cues vs. 
cocaine.
The zones in which hM4Di inhibition were most effective at reducing cued reinstatement 
were centered in RVP, while effective sites for cocaine-primed reinstatement were centered 
in CVP (cue—VP site x drug interaction: F1,16=7.35, p=0.015; prime—VP site x drug 
interaction: F1,25=4.85, p=0.037). VP inhibition was sufficient for these effects, as cases 
with minimal (<5%) hM4Di expression outside VP borders showed equivalent reinstatement 
effects as those with more (<30%) encroachment of expression into adjacent areas 
(Supplemental Fig. 1). CNO had no effects in animals with either GFP virus injections (Syn-
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GFP, lacking the hM4Di gene; n=5 rats; cue: F2,11=0.58, n.s.; prime: F1,8=0.05, n.s.), or no 
virus expression (n=9 rats; cue: F2,18=0.87, n.s.; prime: F2,24=0.28, n.s.; control groups 
combined: cue: F2,28=0.77, n.s.; prime: F2,31=0.22, n.s.; Fig. 2b–c)].
Fos Activation of RVP-VTA Projections During Reinstatement
We next asked whether the role for RVP in cued reinstatement behavior involves projections 
to VTA. First, we examined Fos expression in RVP or CVP VTA-projecting neurons during 
cued reinstatement, or control behaviors (Fig. 3a; Supplemental Fig. 2). The retrograde 
tracer cholera toxin beta subunit (CTb) was injected into rostral or caudal VTA. Animals 
(n=25) were trained to self-administer i.v. cocaine+cues, extinguished, then given a 2 h cue-
induced reinstatement test or control behavioral test, as described in Online Methods. 
Animals were sacrificed immediately after this test session, and VP slices were co-stained 
for Fos and CTb.
In RVP, VTA-projecting (CTb+) neurons were Fos-activated during cued cocaine seeking 
(CS+, n=8 rats), but not during exposure to the extinguished self-administration chamber 
(Ext., n=7), a novel environment (Loco, n=6), or a familiar, non-cocaine associated CS− 
stimulus (CS−, n=4; F3,21=6.6, p=0.002; Fig. 3c). Unlike RVP, CVP projections to VTA 
were not specifically activated during cued reinstatement (F3,21=2.3, n.s.; Fig. 3c; 
Supplemental Fig. 2). Moreover, in individual CS+ animals, the degree of Fos activation of 
VTA afferents from RVP, but not CVP was positively correlated with the degree of cue-
induced cocaine seeking behavior (RVP: r=0.78, p=0.02; CVP: r=−0.54, n.s.; Fig. 3d; 
Supplemental Fig. 2d), indicating that more activity in RVP efferents to VTA is associated 
with more cue-triggered drug seeking.
Validating Inhibition of RVP-VTA Projection with DREADDs
The hM4Di DREADD is trafficked axonally, evidenced by numerous HA+ fibers and 
terminals reliably observed in ventral midbrain after hM4Di vector injection in RVP or CVP 
(Fig. 3b,4a, Supplemental Fig. 3d–e). We examined whether modulation of Gi-coupled 
signaling in VP axon terminals in VTA via local CNO application would alter activity of 
VTA neurons. First, we recorded spontaneous inhibitory postsynaptic currents (sIPSCs) 
from dopamine neurons (verified by tyrosine hydroxylase (TH) immunoreactivity) in VTA 
slices from rats that were injected 6+ weeks prior with the hM4Di vector in RVP (n=7 rats; 
Fig. 4b–c). Perfusion with 5 μM CNO had no effect on sIPSC amplitude (t6=0.94, n.s.; Fig. 
5d), but decreased frequency (t6 = 2.50, p=0.046) and shifted the cumulative distribution of 
inter-event intervals (IEIs) to the right (main effect of IEI duration: F21,264=22.18, 
p=0.0001; and CNO treatment: F1,264=14.42, p=0.0002; Fig. 4e). In slices from Syn-GFP 
injected animals (n=5 cells), which also expressed GFP in RVP neurons and their VTA 
axons, CNO had no effect on sIPSC amplitude (t4 = 0.47, n.s.) or IEIs (t4 = 0.39, n.s.; 
Supplemental Fig. 4). These findings indicate that activation of hM4Di DREADDs on VP 
terminals in VTA decreased GABA release onto VTA dopamine neurons.
We confirmed this finding in vivo, demonstrating that intra-VTA CNO microinjection in 
RVP-hM4Di rats significantly increased firing rate (m=82.5 ± 50.2% increase) in 8 of 9 
“Type 1 neurons” (those meeting conventional electrophysiological criteria for VTA 
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dopamine neurons26; p=0.03; t7 = 2.63; Fig. 4f–g). Conversely, 10 of 14 fast-spiking, short-
waveform “Type 2” VTA neurons (not conventionally dopamine-like) were inhibited (m=
−60.5 ± 12.0% change in discharge) after intra-VTA microinjection of CNO in RVP-hM4Di 
rats (p=0.003; t9 = 3.93; Fig. 4h–i).
Inhibiting RVP Terminals in VTA Blocks Cued Reinstatement
Next, we examined effects of inactivating VP terminals in VTA on cued or cocaine-primed 
reinstatement behavior. RVP hM4Di animals (n=28) were microinjected (in counterbalanced 
order on separate days) with CNO (1 mM/0.3 μl/side) or vehicle (artificial cerebrospinal 
fluid: aCSF) into VTA (n=17 rats) or SN (n=11), 5 min prior to cued or primed 
reinstatement (2 tests each/animal; Fig. 5a). CVP hM4Di animals (n=9) were also injected 
with CNO (0&1 mM/0.3 μl) into VTA, then tested on cued or primed reinstatement (Fig. 5a; 
cannulae sites in Supplemental Fig. 5). Inhibition of RVP terminals in VTA with local CNO 
selectively attenuated cued, but not primed reinstatement (cue: F1,16=27.87, p=0.000075; 
prime: F1,16=0.01, n.s.; Fig. 5b), indicating that activation of the RVP projection to VTA is 
required for drug cues to drive reinstatement of cocaine seeking. In contrast, inactivating 
RVP terminals in SN, or CVP terminals in VTA, had no effects on cued or primed 
reinstatement (RVP-SN inhibition, cue: F1,10=0.21, n.s., prime: F1,10=0.01, n.s.; CVP-VTA 
inhibition, cue: F1,8=0.84, n.s., prime: F1,8=0.37, n.s.; Fig. 5d,f). This indicates that although 
CVP is necessary for cocaine-primed reinstatement (Fig. 2c), its VTA targets are not 
essential for this action.
Inactivating RVP projections to VTA in the absence of cues or priming injections failed to 
affect drug seeking following extinction (n=4 rats; vehicle AL presses m±SEM=8.7±6.7, 
CNO m=4.3±1.7; F1,3=3.9, n.s.). In RVP (n=11) or CVP (n=6) hM4Di animals, neither 
intra-VTA (n=17) nor intra-SN (n=6) CNO had significant effects on general locomotor 
behavior in a familiar environment (no main effect of drug or drug X time interactions; 
Fs<1.7, n.s.; Fig. 5c,e,g), indicating that reinstatement effects of RVP-VTA inhibition are 
more likely motivational than motoric in nature.
RVP Interacts with VTA Dopamine Neurons in Reinstatement
VTA is a complex structure, with dopamine, GABA and glutamate projection neurons, as 
well as interneurons and other local connectivity27–31. Because VP projections modulate 
dopamine and non-dopamine neuron firing in VTA32 (Fig. 4), we asked whether 
reinstatement behavior is affected by contrahemispheric disconnection of RVP from VTA 
dopamine neurons. In transgenic rats that express Cre recombinase in TH neurons (TH::Cre
+ rats)33, we unilaterally transduced RVP neurons with the Syn-hM4Di-HA-GFP lentivirus 
described above. We also injected a double-floxed hM4Di AAV virus (DIO-Syn-hM4Di-
mCherry; Fig. 6a) into the contralateral VTA (n=9 rats) or SN (n=8), yielding reliable and 
anatomically restricted hM4Di expression in unilateral dopamine neurons (Fig. 6b–c; 
Supplemental Fig. 6). A systemic CNO injection in these animals therefore functionally 
disconnected RVP inputs from midbrain dopamine cells bilaterally, while sparing RVP 
connectivity with non-dopaminergic VTA neurons (Fig. 6d). Control groups consisted of 
Cre+ animals with unilateral VTA DIO-Syn-hM4Di-mCherry injections but no virus in RVP 
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(n=6 rats), or Cre− littermates (n=10) with unilateral RVP hM4Di and contralateral VTA 
injections of DIO-Syn-hM4Di-mCherry (but no VTA hM4Di expression).
As shown in Fig. 6, cue-induced reinstatement was markedly attenuated by disrupting the 
RVP-VTA dopamine circuit in this manner (F1,8=37.97, p=0.0003; Fig. 6e). No effects were 
found after similarly disconnecting RVP from SN dopamine neurons (F1,7=0.29, n.s.), or 
after unilaterally inactivating either RVP (F1,9=0.06, n.s.) or VTA dopamine neurons 
(F1,5=0.57, n.s.; Fig. 6e). This indicates that intact connectivity between RVP (not CVP) and 
VTA (not SN) dopamine populations is required for conditioned cues to trigger cocaine 
seeking during reinstatement.
Further Examinations of the Nature of the RVP-VTA Circuit
GABAergic VP projections to VTA can tonically inhibit VTA dopamine neurons5, and 
inactivating this projection with DREADDs can disinhibit dopamine neurons (Fig. 4). We 
therefore asked if disinhibition of VTA dopamine neurons could have contributed to the 
attenuation of reinstatement we observed after inactivating RVP inputs to VTA with 
DREADDs. If so, then direct disinhibition of VTA dopamine neurons with the GABAA 
antagonist gabazine should also attenuate reinstatement. Instead, we observed that intra-
VTA gabazine (10 μM/0.3 μl) strongly increased cued reinstatement (n=6 rats; F2,17=9.43, 
p=0.002; veh vs. 10 μM gabazine active lever: t6=2.62, p=0.04; Fig. 7g–h), and robustly 
induced Fos in nearby dopamine neurons (veh n=3, gabazine n=5 rats; no effect on number 
of TH+ cells: t6=0.2, n.s.; total Fos+ TH+ cells: t4.4=5.55, p=0.001; percent Fos+ TH cells: 
t6=8.84, p=0.0001; Fig. 7a–f). This indicates that simple disinhibition of dopamine neurons 
is not likely the mechanism by which inhibiting RVP inputs to VTA reduces cued 
reinstatement.
In addition to GABA projections, RVP sends numerous VGlut2+ efferents to VTA34; we 
asked whether this glutamatergic projection is required for cued reinstatement. We used 
unilateral DREADD-based RVP inhibition and contralateral VTA microinjection of a 
cocktail of the AMPA/NMDA antagonists CNQX/AP5 (0.7/1.6 mM) to bilaterally 
compromise glutamate projections from RVP to VTA. This did not affect cued reinstatement 
(n=5 rats; t4=1.28, n.s.; Supplemental Fig. 7). In contrast, reinstatement was attenuated when 
all VTA neurons (baclofen/muscimol; 0.3/0.03 mM) were inhibited contralaterally to a 
DREADD-inactivated RVP (RVP/VTA disconnect, n=10 rats: t9=2.81, p=0.02; no effect of 
unilateral VTA baclofen/muscimol alone, n=8: t7=1.03, n.s.; Supplemental Fig. 7). In slice, 
we also explored whether inhibiting RVP inputs to VTA would decrease spontaneous 
excitatory transmission (sEPSCs) onto dopamine neurons. CNO (5 μM) had no effects on 
sEPSC amplitude (t5=0.22, n.s.) or frequency (t5=0.43, n.s.) in TH+ cells (n=6 cells, 
Supplemental Fig. 8). These findings indicate that RVP glutamatergic projections to VTA 
do not directly modulate dopamine neurons, nor are they likely to be necessary for cued 
reinstatement.
Discussion
Here, we describe an RVP-VTA pathway activated by, and necessary for, conditioned cue-
induced reinstatement of cocaine seeking in rats. VP’s involvement in reinstatement depends 
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critically upon both the rostrocaudal position within VP, and the means by which drug 
seeking is reinstated (cues vs. cocaine prime). Cue-triggered drug seeking specifically 
requires both RVP projections to VTA, and functional interactions between RVP inputs and 
VTA dopamine and non-dopamine neurons. In addition to describing a novel double 
dissociation between VP subregions in drug seeking, we also validate the use of Gi-coupled 
DREADDs to inactivate specific neuronal pathways via modulation of DREADD-
expressing terminals, and to functionally disconnect brain circuits in vivo.
VP Roles in Reward Seeking—Much prior research has focused on the portion of VP 
caudal of bregma in rat (CVP), which showed that VP is an important node in 
mesocorticolimbic reward circuits. Lesions or pharmacological inactivation of CVP reduce 
drug- or food-seeking13, 35–38. Many of these VP neurons are spontaneously active, and their 
GABAergic projection to VTA tonically inhibits populations of dopamine neurons there5.
VP efferents to VTA are also acutely activated by rewards and associated cues. For 
example, VP-VTA projections in rats are Fos-activated after acute amphetamine, cocaine 
self-administration, or cued reinstatement of cocaine seeking23, 39, 40, and VP neurons 
phasically fire when salient rewards and their cues are experienced6, 11. In primates, VP 
neurons also fire in relation to reward anticipation, and VP inactivation compromises 
modulation of reward seeking based upon reward expectation22. Similarly, VP is fMRI-
activated by cues for drug or natural rewards in humans41. Our report therefore supports, 
and substantially expands upon the known roles for VP in reward-seeking.
Anatomical and Functional Heterogeneity Within VP—Anatomically, both 
rostrocaudal and mediolateral heterogeneity exists in VP cell morphology, transmitter 
content, sources of afferents, and efferent targets6, 10, 16, 42, 43. A large proportion of 
subcommissural RVP consists of a neurotensin-positive, ventromedial subregion, which 
receives afferents from medial accumbens shell, and sends efferents to mediodorsal 
thalamus and VTA. In contrast, a large proportion of sublenticular CVP consists of a 
calbindin-positive, dorsolateral subregion that receives accumbens core inputs, and projects 
to SN and subthalamic nucleus1. RVP (and adjacent caudal accumbens shell) has been 
described as a transition zone between accumbens and traditional (caudal) VP, with 
connectivity and morphological features distinct from rostral accumbens, pallidal, or 
extended amygdala regions10, 42. Supporting this view, RVP and caudal ventromedial 
accumbens shell project similarly to VTA, and Fos activation of both projections is 
correlated with cue-induced reinstatement behavior (Fig. 3)23.
Previous evidence supports a role for RVP in conditioned motivation, and CVP in the 
rewarding and priming effects of reinforcers themselves. For example, RVP (but not CVP) 
is Fos-activated during motivated behaviors triggered by Pavlovian cues for specific salient 
rewards, and is necessary for these cues to trigger seeking behaviors44, 45. RVP (not CVP) is 
fMRI-activated when people view highly salient, disgusting photographs—again indicating 
a role in conditioned motivational states18. In contrast, GABA agonists microinjected into 
CVP reduce cocaine-primed and stress-induced reinstatement of cocaine seeking35, 36, 
aligning with our observation that DREADD-based inhibition of CVP neurons blocked 
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primed reinstatement (although ours is the first report for a role of VP, more specifically 
RVP, in cued reinstatement of cocaine seeking). Additionally, CVP (not RVP) has been 
linked to the hedonic evaluation of primary rewards in animals and humans18, 19.
Here, we examined the functions of RVP and CVP in cued vs. primed reinstatement of 
cocaine seeking. We showed that RVP (not CVP) is necessary for cues to trigger cocaine 
seeking, whereas CVP (not RVP) is necessary for a cocaine prime to elicit reinstatement. 
Therefore, VP in general is critically involved in promoting relapse-related drug seeking, but 
its rostral vs. caudal aspects differentially mediate the motivational properties of previously 
learned cues vs. cocaine itself.
RVP-VTA Projection Specifically Mediates Cued Drug Seeking
To examine the wider neural circuits with which RVP and CVP interact to drive 
reinstatement, we focused on VP projections to VTA. First, we showed that RVP but not 
CVP projections to VTA are Fos-activated in proportion to cued reinstatement. To test 
whether these RVP efferents to VTA are also necessary for reinstatement, we induced 
hM4Di DREADD expression in RVP or CVP neurons, then microinjected the DREADD 
agonist CNO directly into VTA. This allowed us to specifically inhibit VP-VTA projections, 
but not other VP efferents.
When RVP projections to VTA (but not the adjacent SN) were inactivated in this manner, 
cue-induced reinstatement was abolished, but primed reinstatement was spared. In contrast, 
similar inhibition of CVP projections to VTA failed to affect either cued or primed 
reinstatement. Therefore, RVP projections to VTA are selectively recruited during cued 
reinstatement and are necessary for cues to trigger reinstatement, whereas CVP is necessary 
for a cocaine prime to promote reinstatement via VTA-independent circuitry.
RVP Indirectly Modulates Dopamine Neurons in Reinstatement—We identified a 
functional circuit containing RVP and VTA dopamine neurons (but not CVP, or SN 
dopamine neurons) that is necessary for cues to elicit reinstatement by functionally 
disconnecting RVP from VTA dopamine neurons via hM4Di inhibition of RVP in one 
hemisphere, and simultaneous hM4Di inhibition of VTA dopamine neurons in the 
contralateral hemisphere. This selective, bilateral circuit disruption reduced cue-induced 
reinstatement—indicating that serial connectivity between RVP and VTA dopamine neurons 
is required for cues to trigger cocaine seeking.
VP projections to VTA are predominantly GABAergic3, 5, 32, and consistent with previous 
reports32, we observed that DREADD-based inhibition of RVP inputs to VTA disinhibited 
dopamine neurons by decreasing sIPSC frequency. However, indiscriminate disinhibition of 
dopamine neurons is unlikely to account for attenuated reinstatement after we saw after 
RVP-VTA inactivation. When we directly disinhibited VTA dopamine neurons (as 
evidenced by robust Fos induction) with microinjections of the GABAA antagonist 
gabazine, cued reinstatement was instead increased (Fig. 7). It is therefore likely that 
reinstatement blockade by inhibition of RVP inputs to VTA involves differential modulation 
of heterogeneous VTA neuronal subpopulations, possibly including inhibition of non-
dopaminergic VTA neurons. Interestingly, this modulation appears to be able to supersede 
Mahler et al. Page 8
Nat Neurosci. Author manuscript; available in PMC 2014 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
reinstatement-promoting effects of dopamine neuron disinhibition, which can also occur 
when the RVP-VTA circuit is inactivated. Systematic mapping of RVP inputs to VTA 
neuronal subpopulations will be required to further characterize the complexities of this 
novel, addiction-related circuit.
In addition to GABA efferents, RVP sends substantial Vglut2-containing projections to 
VTA 34. However, DREADD-based inhibition of RVP-VTA projections did not reduce 
spontaneous excitatory transmission to TH+ cells, nor did a contralateral disconnect-based 
disruption of RVP glutamate projections to VTA affect cued reinstatement—arguing against 
a reinstatement-related glutamatergic RVP-VTA projection.
Conclusions
Here we showed that RVP projections to VTA are activated during, and are necessary for, 
cue-induced reinstatement, and that this requires modulation of VTA dopamine neurons. 
However, this modulation does not likely involve direct GABAergic or glutamatergic RVP 
projections onto dopamine neurons. Instead, inhibiting RVP inputs to VTA yielded both 
excitation of Type 1 VTA neurons, and inhibition of Type 2 neurons in vivo (Fig. 4). Type 1 
neurons, which displayed conventionally dopaminergic electrophysiological characteristics, 
were excited by VP inhibition—consistent with our finding that inactivation of RVP inputs 
to VTA attenuates GABA inputs to TH+ neurons (Figure 4b–e). However, indiscriminate 
disinhibition of dopamine neurons with a GABAA antagonist did not impede reinstatement, 
but instead robustly facilitated it. Therefore, although our disconnection study revealed that 
dopamine neurons are needed for VP regulation of relapse, VP’s role in reinstatement does 
not depend upon general disinhibition of dopamine neurons in VTA.
One possibility is that VP neurons selectively regulate a select subpopulation of VTA 
dopamine neurons during cued drug seeking. Notably, VTA contains fast-firing, thin-
waveform dopamine neurons46, 47, and it is possible that these could be the Type 2 neurons 
whose activity is suppressed after RVP-VTA inactivation (Fig. 4h–1). However, this seems 
unlikely because inhibitory inputs to dopamine neurons recorded in vitro here were nearly 
always reduced by DREADD-based inactivation of RVP-VTA projections (Fig. 4e). 
Therefore, we hypothesize that complex, subpopulation-specific VP modulation of VTA 
neurons is necessary for cues to elicit relapse to cocaine seeking. These findings call for 
additional research to characterize the relative connectivity of VP GABA, glutamate, 
acetylcholine, and peptide-containing neurons with VTA neuronal subpopulations, and to 
further define the roles for each in reward seeking.
In sum, we have described a novel pathway, the projection from RVP to VTA, which is 
necessary for conditioned drug seeking in a model of relapse in addiction. Furthermore, this 
circuit-behavior relationship requires RVP modulation of both non-dopamine and dopamine 
VTA neurons. We also showed that VP subregions play qualitatively different roles in drug 
seeking behavior elicited by either conditioned stimuli or drug itself. Together, these 
findings both expand the known circuitry of conditioned motivation48, and also highlight 
important next directions for untangling the neural substrates of reward seeking behavior—
especially in appetitive disorders such as drug addiction.
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Online Methods
Subjects
159 male Sprague Dawley rats (250–350g; Charles River), and 45 outbred male Long Evans 
TH::Cre rats (hemizygous Cre+ n=35; Cre− littermates n=10)33 were single or pair housed 
in a 12 h:12 h reverse light cycle vivarium (all tests conducted in dark period). No statistical 
methods were used to predetermine sample sizes, but they are similar to those reported in 
previous publications15, 19, 23, 49. All procedures were approved by MUSC’s Institutional 
Animal Care and Use Committee.
Surgical Procedures
Animals were anesthetized with ketamine/xylazine/meloxicam (56.5/8.7/1.0 mg/kg), and 
implanted with indwelling jugular catheters. They received 20–30 nl injections of 0.5% CTb 
unilaterally in VTA, or 1 μl uni- or bilateral virus injections into RVP, CVP or VTA. VTA 
CTb and VP lentivirus injections were made by pneumatic pressure via a glass pipette (for 
CTb: 15–20 μm tip; for lentivirus: 30–45 μm tip) over 5 min and left in place 15–20 min. In 
TH::Cre animals, midbrain injections of an AAV floxed DIO-Syn-hM4Di-mCherry virus 
were made over 10 min through a Hamilton microinjection syringe. For bilateral VTA CNO 
or gabazine, or unilateral VTA glutamate antagonist or GABA agonist microinjections in 
behaving animals, guide cannulae were implanted 2 mm dorsal to VTA or SN.
Viral Constructs
hM4Di Inhibition of Ventral Pallidum—To transduce VP neurons with hM4Di 
DREADDs, we used a synapsin promoter-driven lentiviral vector with a GFP reporter, 
custom packaged (VSV-G envelope) by University of Pennsylvania vector core. To assist 
with identification, the hM4Di has an N-terminal hemagglutinin (HA) tag, and an IRES GFP 
reporter (Syn-hM4Di-HA-GFP; Fig. 1a). A Syn-GFP lentivirus (lacking the DREADD gene) 
was used to control for non-specific virus effects (Fig. 2b–c; Supplemental Fig. 5).
hM4Di Inhibition of Midbrain Dopamine Neurons—In TH::Cre transgenic rats33, an 
AAV containing a double-floxed, inverted open reading frame hM4Di-mCherry sequence 
(DIO-Syn-hM4Di-mCherry; University of North Carolina Vector Core) was microinjected 
into ventral midbrain to express hM4Di receptors selectively in TH neurons of VTA or SN 
(Fig. 6a).
Localization of DREADD Expression
hM4Di receptor expression in cell bodies and processes was visualized with 
immunohistochemistry for HA, GFP, or mCherry tags (described below). Containment of 
transduction sites within RVP or CVP, or VTA or SN dopamine cells, was confirmed by co-
staining for substance P (SP; defining borders of VP), or TH (defining VTA and SN), and a 
brain atlas50. A synapsin promoter virus was employed in VP, so some expression was 
observed outside the borders of RVP or CVP in most animals. Animals with more than 30% 
of DREADD expression observed outside RVP or CVP were excluded from analyses (n=7). 
For animals with RVP virus injections, no more than 20% of DREADD-expressing tissue 
encroached into CVP (i.e., caudal of bregma), or vice versa. Animals injected with the Syn-
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GFP control virus in VP had comparable GFP expression patterns to hM4Di animals. For 
TH::Cre rats, hM4Di expression was robust in either VTA or SN, and was restricted almost 
exclusively to TH+ cell bodies and processes [% mCherry+ neurons coexpressing TH: m
±SEM=97.5±0.7%; Fig. 6b–c, Supplemental Fig. 6]. mCherry expression was not observed 
in the contralateral hemisphere, nor did expression extend substantially into the SN of VTA-
injected animals, or into VTA of SN-injected animals (Fig. 6b–c).
Electrophysiological Validation of DREADD-Based Inhibition of VP Neurons and Efferents
In Vitro Electrophysiology in Brain Slices—Brain slices from VP Syn-hM4Di-HA-
GFP (n=6 rats), and Syn-GFP animals (n=2) were prepared as previously described49. Slice 
physiology data collection and analysis was not performed blind to the experimental group. 
Horizontal sections containing VTA were transferred to a 32–34°C chamber containing a 
carbogen-bubbled aCSF solution.
Slices were transferred to a recording chamber and perfused with 32°C aCSF at 2 ml/min. 
Neurons were visually identified under infrared light using Dodt gradient contrast imaging. 
Recording pipettes with a resistance of 1–3 MΩ were filled with internal solution containing: 
(in mM): CsCl (120), HEPES (10), MgCl2 (2), EGTA (1), Na2ATP (2), NaGTP (0.3), 0.2% 
biocytin; 295 mOsm, pH = 7.3. To isolate sIPSCs, recording aCSF was supplemented with 
AMPA/NMDA antagonists (NBQX/AP5; 10 μM/100 μM; Abcam), and for sEPSC 
recordings, picrotoxin (100 μM; Tocris) was added to ACSF. Neurons medial to the nucleus 
of the accessory optic tract were targeted for patch clamp (in the vicinity of dense, GFP-
expressing RVP afferents), and whole-cell mode was achieved while holding the cell at -
−70mV.
Data were acquired using an Axon MultiClamp 700B amplifier and an ITC-18 digital 
interface (HEKA Instruments) controlled by AxographX software. Recordings were filtered 
at 4 kHZ and acquired at 10 kHz, and sIPSCs were detected and analyzed using the 
template-matching event-detection algorithm in AxographX. Detection parameters were set 
at amplitude >4 pA, and acquired events were visually inspected before averaging. We 
recorded at least 150 spontaneous currents during a baseline period, and following 10 min of 
5 μM CNO perfusion. Series resistance (Rs) was monitored throughout the recording and an 
experiment was discontinued if Rs exceeded 25 MΩ or changed more than 25%.
In vivo electrophysiology—In vivo electrophysiology data collection and analysis were 
performed blind to experimental conditions. Glass recording pipettes (5–12 MΩ) were filled 
with 2% pontamine sky blue in 0.5 M sodium acetate. A glass injection pipette (20 μm tip) 
glued ~150 μm behind the recording tip delivered 60 nl of 100 μM CNO to VP or VTA 
neurons via brief pneumatic pulses. Multiple CNO applications occurred in each animal 
upon different cells, each separated by >30 min. Signals were amplified and filtered (0.3–5 
kHz) using a Model 1600 Neuroprobe Amplifier (A-M Systems) and a BMA 200 
Bioamplifier (CWE), before digital conversion and recording to Spike 2 (v5.21) via a Micro 
1401 MkII interface (CED). Body temperature was maintained at 36.0–37.5°C throughout 
recording.
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Recorded VP neurons were located nearby prior virus injections, and identified by their 
firing rates and waveforms, as previously reported12. For confirmation of recording 
locations, markings 1 mm above and immediately below recording tracks in each VP and 
VTA site were made by iontophoretic dye deposits immediately prior to perfusion. VTA 
“Type 1” neurons were identified by electrophysiological criteria traditionally describing 
dopamine neurons26, including (1) biphasic or triphasic waveform >2.5 ms in duration, (2) 
>1.1 ms from spike onset to negative trough, and (3) spontaneous firing rate <10 Hz. All 
cells included in analyses were from confirmed recordings in VP or VTA.
Drugs and Tract Tracers
Cocaine HCl (NIDA) was dissolved in 0.9% sterile saline. CTb (Sigma) was dissolved at 
0.5% in 0.1 M PBS. CNO was obtained from the NIH RAID program (Jürgen Wess; 
NIDDK). For systemic administration, CNO (0, 0.1, 1, 10 & 20 mg/kg) was dissolved in 5% 
DMSO, then diluted to a 1 ml/kg volume with 0.9% saline. For intracranial administration, 
CNO was dissolved in aCSF to 100 μM (in vivo electrophysiology) or 1 mM (behavioral 
microinjection), or 5 μM in vitro. Gabazine (10&100 μM), baclofen/muscimol (0.3/0.03 
mM), and CNQX/AP5 (0.7/1.6 mM; all from Sigma) were dissolved in aCSF for 0.3 μl VTA 
microinjections.
Behavioral Training and Testing Procedures
Behavioral training and testing took place in standard Med Associates operant chambers 
described elsewhere23. Rats underwent 10 daily 2 h self-administration sessions (>10 
cocaine infusions/day, 0.2 mg/50 μl infusion). Pressing one lever yielded a 3.6 s cocaine 
infusion, tone, and light above the active lever (FR1 schedule), followed by a 20 s timeout, 
when pressing was recorded but did not yield cocaine or cues (Figure 2a). Inactive lever 
presses were recorded, but had no consequences. Animals then received 7+ d of extinction 
training (until criterion: <25 presses for 2 consecutive days), where lever presses yielded 
neither cocaine nor cues.
During 2 h cue-induced reinstatement tests, active lever presses yielded cocaine cues, but no 
cocaine. For cocaine priming tests, 10 mg/kg i.p. cocaine was administered immediately 
prior to the 2 h test, where lever presses yielded neither cocaine nor cues. For the CTb/Fos 
experiment, animals were perfused immediately after one of the following 2 h test sessions: 
CS+ reinstatement, an additional extinction session, exposure to a novel environment, or 
exposure to a discrete CS− (details in23). Behavior during the first 30 min of tests (which 
most influences Fos protein measured 90 min later) was compared to neuronal activation 
(Fig. 3).
Animals that received systemic CNO had 3 cued, and 3 cocaine primed reinstatement tests 
each. 30 min prior to each test, RVP (n=16) or CVP (n=17) Syn-hM4Di-HA-GFP animals, 
VP Syn-GFP animals (n=5), and animals with no virus expression (n=9) received 
counterbalanced i.p. injections of vehicle, and 2 doses of CNO [0.1 mg/kg: n=25; 1.0 mg/kg: 
n=25; 10 mg/kg: n=26; 20 mg/kg: n=30). Other animals received counterbalanced intra-
VTA (after RVP or CVP Syn-hM4Di-HA-GFP) or intra-SN (after RVP Syn-hM4Di-HA-
GFP) microinjections of vehicle (aCSF) and CNO (1 mM/0.3 μl) 5 min prior to each of 2 
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cued, and 2 primed reinstatement tests. Some of these animals were later habituated to an 
open field for 2 d, then locomotor activity after vehicle and CNO was tested over 2 d, 48 h+ 
apart (intra-VTA CNO: 0&1 mM/0.3 μl, n=23). TH::Cre animals (RVP Syn-hM4Di-HA-
GFP +VTA DIO-Syn-hM4Di-mCherry: Cre+ n=9, Cre- n=10; RVP Syn-hM4Di-HA-GFP
+SN DIO-Syn-hM4Di-mCherry: Cre+ n=8; VTA DIO-Syn-hM4Di-mCherry only n=6) 
received i.p. vehicle or CNO (10 mg/kg) 30 min before each of two cue-induced 
reinstatement tests. Animals with unilateral RVP Syn-hM4Di-HA-GFP +contralateral VTA 
cannulae underwent 3 cued reinstatement tests after unilateral VTA vehicle+i.p. CNO (10 
mg/kg), and two of the following: intra-VTA baclofen/muscimol+ i.p. CNO (n=12 rats), 
intra-VTA CNQX/AP5+ i.p. CNO (n=5), intra-VTA baclofen/muscimol+ i.p. vehicle (n=8). 
For bilateral VTA gabazine, animals also underwent 2–3 reinstatement tests, after vehicle 
and 10 μM (n=7 rats), and 100 μM (n=4) gabazine (high dose testing was discontinued due 
to intense nonspecific locomotor activation). Vehicle/CNO injection order was 
counterbalanced in all cases.
Tissue Preparation and Staining
Animals were deeply anesthetized and perfused with 0.9% saline, followed by 4% 
paraformaldehyde. Brains were postfixed in 4% paraformaldehyde, cryoprotected, and 
sliced at 30–40 μm on a cryostat. For CTb/Fos staining, IHC procedures were described 
previously23. To visualize hM4Di expression, we performed immunohistochemistry for HA, 
mCherry, and/or GFP tags. VP borders were defined via immunoreactivity for SP4, and 
dopamine cells were identified as TH immunoreactive. All tissue was first incubated in 3% 
normal donkey serum PBS-Triton (PBST; 2 h), then in primary antibodies in PBST 
overnight at RT. The following primary antibodies were used in these experiments (1 or 2 
antibodies/tissue sample): mouse anti HA (1:500; Covance catalogue number: MMS-101P), 
rabbit anti DsRed (mCherry tag; 1:500; Clontech catalogue number: 632496), chicken anti 
GFP (1:2000; Abcam catalogue number: ab13970), rabbit anti SP (1:5000; Immunostar 
catalogue number: 20064), and mouse anti TH (1:1000, Immunostar catalogue number: 
22941). For fluorescent stains, sections were incubated 4 h at RT in fluorescent conjugated 
secondary antibodies [donkey anti mouse 488 (HA and TH: 1:500; Invitrogen catalogue 
number: A21202), donkey anti rabbit 594 (Ds Red, TH, and SP: 1:500; Invitrogen catalogue 
number: A21207), donkey anti chicken 488 (GFP, Fos: 1:500, Jackson catalogue number: 
703545155)]. Slices were mounted and coverslipped with Citifluor mounting medium. For 
DAB visualization of HA, slices were incubated 2 h in a biotinylated donkey anti mouse 
secondary antibody (1:500; Jackson catalogue number: 715066151), and amplified with an 
avidin-biotin complex (1:500; Vector). Tissue was dehydrated and coverslipped with 
Permount. After slice physiology experiments, tissue was fixed 48h in 4% 
paraformaldehyde, sectioned, incubated in 5% normal goat serum PBST (7min), rabbit anti 
TH (1:1000; Millipore catalogue number: AB152) and Avidin TexasRed (1:500; Life 
Technologies catalogue number: A820) overnight at 4°C, and Alexafluor 488 goat anti-
rabbit IgG (Life Technologies catalogue number: A11008) for 2h. All antibodies were 
previously validated for specificity, as described on the manufacturer’s websites and the 
Journal of Comparative Neurology antibody database.
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Quantification of CTb/Fos staining
Fos expression in CTb+ cells was analyzed as a function of rostral/caudal position within 
VP, using a quantification strategy described in a previous report, where other analyses of 
this tissue were described23. Coronal sections at ~250 μm intervals throughout the rostral/
caudal extent of VP were photographed at 10X magnification, and montaged with the Stereo 
Investigator Virtual Slice Module (MBF Bioscience) to preserve anatomical landmarks. All 
CTb+ neurons (with or without Fos) within VP ipsilateral to VTA CTb injection were 
counted on each slice by an observer blind to experimental group, and primary analyses 
examined the percentage of total CTb neurons that were Fos+ (Fig. 3, Supplemental Fig. 2), 
or average number of CTb cells per rostro-caudal level (Supplemental Fig. 3). To quantify 
VTA gabazine (vehicle or 10 μM)-induced Fos, z-stack images were taken at 20X 
magnification of TH (red) and Fos (green) immunoreactivity, 90–110 μm lateral of VTA 
microinjection sites (Fig. 7). TH+ and Fos+ neurons were quantified in Photoshop using 
ImageJ-deconvolved images. 2–3 images/microinjection were quantified and averaged for 
each animal.
Analysis and Statistics
To examine reinstatement-related Fos expression in VTA-projecting neurons within RVP 
and CVP, total CTb+, and CTb+/Fos+, cells in VP (ipsilateral of VTA CTb injections) were 
quantified at ~250 μm intervals in each animal. One-way ANOVA (with Tukey posthoc 
comparisons) were used to analyze percentages of Fos+ CTb neurons between behavioral 
groups. Average percentages of Fos+ CTb neurons in RVP (rostral of bregma) or CVP 
(caudal of bregma) for each animal were also correlated with active lever pressing in the 
first 30 min of cued reinstatement, 90 min before sacrifice (Pearson’s test). For gabazine-
induced Fos in VTA, average TH+, and TH+/Fos+ neurons were computed for each animal 
after bilateral vehicle (n=3 rats) or gabazine (n=5), and compared with between-subjects t-
tests.
Effects of systemic CNO on cued or primed reinstatement were analyzed with mixed 
ANOVAs for CNO dose (between subjects variable) X lever (active or inactive; within 
subjects) for each behavioral group (RVP Syn-hM4Di-HA-GFP, CVP Syn-hM4Di-HA-GFP; 
Syn-GFP, or no virus). Repeated measures drug X lever ANOVAs tested effects of CNO in 
VTA or SN on cued or primed reinstatement in RVP or CVP Syn-hM4Di-HA-GFP animals, 
and systemic CNO on cued reinstatement in TH::Cre rats. One way ANOVAs were used to 
test effects of bilateral VTA gabazine, and contralaterally disconnecting RVP from VTA, or 
VTA glutamate, on cued reinstatement. Tukey or Bonferroni-corrected t-test posthoc 
analyses were used as appropriate to determine the nature of significant main effects and 
interactions. All tests were two-tailed, and normality of data distribution was tested with 
Mauchly’s test of Sphericity (Greenhouse-Geisser corrected if necessary).
For in vitro electrophysiology, the change in firing rate of VP or VTA neurons was 
determined from 100 s epochs immediately before vs during CNO application with paired 
samples t-tests comparing average pre- vs. post- CNO sIPSC or sEPSC amplitude or 
frequency, and 2-way ANOVAs with Bonferroni posthocs. Results were normalized to pre-
CNO firing rate (100%) for each cell. In vivo, two-tailed t-tests or Wilcoxon signed-rank 
Mahler et al. Page 14
Nat Neurosci. Author manuscript; available in PMC 2014 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
paired sample tests were used to compare pre- and post-CNO firing rates in VP and VTA 
(depending on normality computed by D’Agostino-Pearson omnibus test). Silenced neurons 
were included in analyses if the original waveform returned within 200 s post-CNO 
application. Baseline firing rates of VP neurons were compared using a two-tailed unpaired 
t-test with Welch’s correction due to a significant F-test for unequal variance.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. hM4Di inhibitory DREADD expression and function
a) Syn-hM4Di-HA-GFP lentivirus used to express hM4Di DREADDs under a neuronal-
specific human synapsin promoter (Syn) in RVP or CVP. b) Typical staining for HA-tagged 
hM4Di after bilateral injections into RVP. Scale bar=1 mm. c) HA-tagged hM4Di receptors 
are expressed on cell bodies and processes (black staining) in VP (neutral red counterstain). 
Scale bar=50 μm. d) Typical HA expression (green) in RVP, largely contained within VP 
borders (defined with SP counterstain in red). e) Typical HA expression in CVP, largely 
contained within VP borders (as defined in d). Images in b–e are representative of DREADD 
expression seen in experimental groups, ns listed in Results. f) In animals with Syn-hM4Di-
HA-GFP in RVP or CVP, local application of 100 μM CNO onto extracellularly recorded 
VP neurons in vivo (via double barrel glass pipette) inhibited firing rates in the vast majority 
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of neurons tested (19/24). g) Typical change in discharge rate of a VP neuron (waveform 
inset) after local CNO application (shaded region).
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Figure 2. Effects of inactivating rostral or caudal VP on reinstatement of cocaine seeking
a) Daily m±SEM cocaine infusions and active/inactive lever presses for the last 6 days of 
criterion self- administration (>10 infusions/day), and active/inactive lever presses for the 
first 7 days of extinction training. b) Active lever presses during cue-induced reinstatement 
following different doses of the DREADD agonist clozapine-n-oxide (CNO; dose=bar color; 
vehicle, 0.1, 1, 10, 20 mg/kg), in animals with bilateral RVP or CVP Syn-hM4Di-HA-GFP 
virus, bilateral VP control virus (Syn-GFP), or no virus expression. Inactive lever presses 
during reinstatement are shown with overlaid black bars. *Vehicle vs. 10 mg/kg CNO: 
p=0.001, vehicle vs. 20 mg/kg CNO: p=0.015. c) Active and inactive lever presses during 
cocaine primed reinstatement following different doses of CNO (Vehicle, 10, 20 mg/kg), in 
animals with RVP or CVP Syn-hM4Di-HA-GFP virus, or controls (Syn-GFP or no virus 
expression animals). *Vehicle vs. 20 mg/kg CNO: p=0.008. Bars and lines=m±SEM. d) The 
anatomical localization of virus expression sites (as visualized with HA or GFP 
immunoreactivity) is represented for animals injected with Syn-hM4Di-HA-GFP in RVP 
(black) or CVP (grey), or Syn-GFP (grey; inset).
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Figure 3. Rostral VP projections to VTA are Fos-activated during cued reinstatement
a) Predominantly ipsilateral projections from RVP and CVP to VTA are diagrammed in the 
horizontal plane. b) Axon terminals in VTA express the anterogradely-transported, HA-
tagged hM4Di receptor (black axonal processes) after Syn-hM4Di-HA-GFP injection in 
ipsilateral RVP (red Nissl counterstain in VTA). Coronal view, scale bar=50 μm. Image is 
representative of VP axonal DREADD expression in VTA of experimental animals, group 
ns listed in Results. c) Mean±SEM percentages of VTA-projecting (CTb+) RVP or CVP 
cells that express Fos after cue-induced reinstatement (CS+), or control behavioral 
conditions, where animals were exposed to: the extinguished self-administration 
environment without cues or cocaine (Ext), a tone/light stimulus not associated with cocaine 
(CS−), or a locomotion- enhancing novel environment (Loco). A greater proportion of VTA-
projecting neurons in RVP were Fos-activated in CS+ than in control animals [*CS+ 
different from: Ext (p=0.01), CS− (p=0.005), and Loco (p=0.025)]. No significant behavior-
specific activation of VTA-projecting neurons was detected in CVP. Bars=m±SEM. d) Cue-
induced reinstatement behavior was positively correlated with Fos activation of VTA-
projecting neurons in RVP (*Pearson correlation: p=0.02), but not CVP (not significant).
Mahler et al. Page 21
Nat Neurosci. Author manuscript; available in PMC 2014 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 4. Inactivating rostral VP afferents modulates VTA cell firing
a) hM4Di receptors (green) are expressed on RVP axon terminals in the vicinity of TH-
labeled dopamine neurons (red) in VTA. Scale bar=30 μm. Image is representative of VP 
axonal DREADD expression in VTA of experimental animals, ns listed in Online Methods. 
b) In slice electrophysiology experiments, recorded neurons were filled with biotin, labeled 
with avidin (red), and identified as dopaminergic by co-labeling for TH (green). Scale 
bar=10 μm. c) Representative traces from VTA dopamine neurons are shown in baseline 
conditions (top, black), and after CNO (bottom, red; scale=20 pA, 200 ms). d) CNO had no 
effect on the cumulative distribution or mean (inset) sIPSC amplitude. Points=m±SEM, 
Lines in inset=individual raw values. e) CNO shifted the inter-event interval cumulative 
distribution to the right (*baseline vs. CNO, p=0.0002) and decreased mean sIPSC 
frequency (Inset, *baseline vs. CNO, p=0.046). Points=m±SEM, lines in inset=individual 
raw values. f) In vivo, 8/9 putatively dopaminergic “Type 1” neurons in VTA were excited 
by local application of CNO in the vicinity of hM4Di-expressing RVP terminals in VTA. g) 
Rate histogram demonstrating effect of local CNO application in vivo (60 nl; shaded region) 
on firing of a “Type 1” neuron (waveform inset) in VTA of RVP-hM4Di animal. h) 10/14 
fast-firing, short-waveform “Type 2” neurons were inhibited by local application of CNO in 
vivo, in the vicinity of hM4Di-expressing RVP terminals in VTA. i) Example change in 
discharge rate of “Type 2” neuron (waveform inset) in VTA after local CNO application in 
vivo (60 nl; shaded region) in a RVP- hM4Di animal.
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Figure 5. Inactivating rostral VP projection to VTA blocks cued reinstatement
a) Projections from RVP to VTA or SN, or from CVP to VTA, were transiently inactivated 
by local midbrain microinjection of CNO amongst VP axon terminals expressing hM4Di 
receptors. b) Inactivation of VTA terminals from RVP blocked cue-induced (Cue), but not 
cocaine primed (Prime) reinstatement of cocaine seeking. Active lever pressing during the 
last day of extinction training (Ext., bars at left), and reinstatement after VTA vehicle (white 
bars) or VTA CNO (grey bars) are shown. Inactive lever presses are represented with black 
bars at bottom. * p<0.001. c) Inactivating RVP projections to VTA did not affect horizontal 
(top graph) or vertical (rearing; bottom graph) locomotion in a familiar environment. 
Locomotion (beam breaks) during 30 min bins in the 2 h session is shown after VTA 
microinjection of vehicle (black lines) or CNO (grey lines). d, e) Inactivation of CVP 
efferents to VTA did not affect cue-induced or cocaine-primed reinstatement, nor did it 
significantly affect horizontal locomotion or rearing. f, g) Inactivation of RVP projections to 
SN failed to affect reinstatement or locomotor behavior. Bars and lines=m±SEM.
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Figure 6. Functional disconnection of rostral VP projection to VTA dopamine neurons blocks 
cue-induced reinstatement
a) A DIO-Syn-hM4Di-mCherry AAV construct was used to selectively express mCherry-
tagged hM4Di receptors in dopamine cells in TH::Cre+ transgenic rats. b) hM4Di 
expression is shown in a representative animal with DIO-Syn-hM4Di-mCherry injection in 
VTA. Immunolabeling for TH identifies dopamine neurons (green), and mCherry (red) 
identifies hM4Di-expressing neurons in VTA. Nearly all hM4Di-expressing neurons were 
dopaminergic. VTA-injected animals did not show substantial hM4Di expression laterally in 
SN, or in the contralateral VTA. Scale bar=500 μm. Inset shows hM4Di+TH+ cell at high 
magnification. c) hM4Di expression is shown in a representative animal with DIO-Syn-
hM4Di-mCherry injections in SN. Minimal expression in VTA was observed. Scale bar=500 
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μm. Equivalent expression observed in behaviorally tested rats; VTA n=9, SN n=8. d) 
Unilateral Syn-hM4Di-HA-GFP injections were made in RVP, and DIO-Syn-hM4Di-
mCherry injections were made in the contralateral VTA or SN of TH::Cre+ rats, or VTA of 
Cre- littermates. When systemic CNO is administered, serial connectivity between VP and 
midbrain dopamine populations is compromised bilaterally via unilateral hM4Di inhibition 
of RVP, and contralateral hM4Di inhibition of dopamine neurons. e) Active and inactive 
lever pressing during cue-induced reinstatement in RVP/VTA dopamine contralateral 
disconnect animals. Pressing during late extinction (Ext., grey bar at left), and cued 
reinstatement after vehicle (white bars) or CNO (10 mg/kg; red bars) are shown. All 
contralateral disconnect animals received unilateral RVP Syn-hM4Di-HA-GFP injections, 
and contralateral DIO-Syn-hM4Di-mCherry injections into VTA or SN of TH::Cre+ rats. 
Unilateral RVP inactivation rats (RVP hM4Di) were Cre negative, and received unilateral 
RVP hM4Di virus, plus contralateral VTA dopamine hM4Di virus (though the latter did not 
cause hM4Di expression in these Cre- rats). Unilateral VTA dopamine inactivation rats 
(VTA dopamine hM4Di) were Cre+, and received only unilateral VTA dopamine hM4Di 
virus. Only contralateral disconnection of RVP from VTA dopamine neurons reduced cued 
reinstatement below control levels. *p<0.001. Bars=m±SEM.
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Figure 7. GABAA-mediated disinhibition of VTA dopamine neurons enhances cue-induced 
reinstatement
a) Example of Fos staining after nearby VTA gabazine microinjection (10 μM/0.3 μl). b) 
Example tyrosine hydroxylase (TH) staining of the same tissue. c) Overlay of Fos and TH 
staining. d) Magnified view of Fos+TH overlay. Arrows point to co-labelled neurons. n=5. 
e) Compared to vehicle microinjection, gabazine induced Fos in TH+ neurons, but did not 
affect the number of TH+ neurons. f) Gabazine increased the percentage of TH+ neurons 
that expressed Fos. g) Gabazine injection sites within VTA from cue-induced reinstatement 
animals. Gabazine was injected at equivalent sites as Fos/TH stained section in panel a. h) 
VTA gabazine (10 μM) increased active, but not inactive lever pressing during cued 
reinstatement. In a subset of animals, gabazine (100 μM) robustly increased pressing on both 
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levers, which was very likely related to intense non-specific locomotor activation observed. 
*p<0.05. Bars=m±SEM. Scale bar=100 μm.
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